Is iShares Biotechnology ETF halal to invest in?

As of September 2026, iShares Biotechnology ETF IBB is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is iShares Biotechnology ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes iShares Biotechnology ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for iShares Biotechnology ETF updated?

The Shariah compliance status of iShares Biotechnology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like iShares Biotechnology ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of iShares Biotechnology ETF?

You can check the latest Shariah compliance status of iShares Biotechnology ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

iShares Biotechnology ETF IBB

IBB Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, iShares Biotechnology ETF is classified as not halal.

NOT HALAL

Is iShares Biotechnology ETF Halal?

Shariah Compliance Analysis of IBB ETF

US Equity Health Care

No. As of September 2026, iShares Biotechnology ETF (IBB) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. iShares Biotechnology ETF does not pass Musaffa's business and financial screening criteria.

IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

iShares Biotechnology ETF (IBB) Chart

Key Statistics of iShares Biotechnology ETF (IBB)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
93.33%
Other
6.64%
Materials
0.03%

FAQ's for iShares Biotechnology ETF (IBB)

As of September 2026, iShares Biotechnology ETF IBB is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes iShares Biotechnology ETF using these criteria to determine its compliance status.
The Shariah compliance status of iShares Biotechnology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of iShares Biotechnology ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.